Resistance of Gram-Negative Bacteria to Cefepime-Enmetazobactam: A Systematic Review

Cefepime-enmetazobactam is a novel β-lactam/β-lactamase inhibitor combination showing good activity against multidrug-resistant (MDR) Gram-negative bacteria producing a variety of β-lactamases. In this systematic review, we aimed to evaluate the available data on resistance to this drug. We performe...

Full description

Bibliographic Details
Published in:Pathogens
Main Authors: Matthew E. Falagas, Laura T. Romanos, Dimitrios S. Kontogiannis, Katerina Tsiara, Stylianos A. Kakoullis
Format: Article
Language:English
Published: MDPI AG 2025-08-01
Subjects:
Online Access:https://www.mdpi.com/2076-0817/14/8/777